Data Sheet | January 14, 2025
NULISAseq™ Inflammation Panel 250
Get the Resource
Download NowWith the NULISAseq Inflammation Panel 250, Sapient can perform broad and deep profiling of inflammatory and immune response, including measure of low-abundance cytokines, chemokines, and inflammatory mediators – all with industry-leading assay sensitivity.
The Inflammation Panel comprehensively measures 250+ biomarkers representing the most relevant and low-abundance inflammation targets in blood-based and CSF biofluids, including cytokines such as IL-4, IL-5, IL-17, IL-30, and IL-33.
As a Certified Service Provider of Alamar Biosciences NULISA™ panels and assays, you can tap Sapient’s deep expertise in Alamar’s technologies and in multi-omics data and insight generation to obtain robust measures of hard-to-assay biomarkers that represent important modulators of immune processes.
Download the data sheet to learn how the NULISAseq Inflammation Panel enables:
- The broadest coverage of >250 cytokines and chemokines with unmatched detectability and signal to noise ratio
- Scalable multiplexing of hundreds of biomarkers from a single 25µL sample, without loss of sensitivity
- Measure of inflammation response across ~12 logs of protein abundance
- High reproducibility with median CVs <10% across measures
See how NULISA panels complement our mass spectrometry-based proteomics services by allowing for precise quantitation of low-abundance cytokines and chemokines that are not amenable to mass spectrometry measure – enabling us to provide a complete solution to cover the wide dynamic range of proteins in plasma.
